MiMedx Group Inc. Agrees to Pay $6.5 Million to Resolve False Claims Act Allegations of False Commercial Pricing Disclosures
MiMedx Group Inc., a Georgia biopharmaceutical company that manufactures and sells human tissue grafts, will pay $6.5 million to resolve allegations that it misrepresented its commercial pricing to the Department of Veterans Affairs, and charged them inflated prices for its products.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.